Shivalik Rasayan plans equity raise; no size or price yet
Board to meet July 23 to consider a preferential, rights, or QIP issue. The nano-cap has not disclosed how much it wants or why.
— 2 earlier stories on Shivalik Rasayan Ltd. →What's new
- Board will meet on July 23, 2026, to discuss issuing equity or convertible securities.
- Options include preferential issue, rights issue, QIP, or other modes.
- No details on quantum, pricing, or purpose of the proposed fundraising.
Why this matters
For a nano-cap like Shivalik Rasayan, even a modest equity raise can be materially dilutive. The company recently reported a 41% drop in annual net profit, and the lack of specifics heightens uncertainty about its capital needs.
What we're watching
- The board's decision on July 23 and any disclosed size or structure.
- Management's commentary on the purpose of the funds.
- Stock price reaction given the recent profit decline and potential dilution.
The full read
Shivalik Rasayan, a nano-cap agrochemicals company with a market cap of ₹339 crore, has called a board meeting for July 23 to consider raising equity or convertible securities. The methods on the table, including preferential issue, rights, QIP, or other modes, are all dilutive. That is all the market knows for now. No size. No price. No use of proceeds. The timing is notable: the company's annual net profit for FY26 dropped 41% to ₹817.25 lakhs, and it declared a modest 10% dividend. Trailing revenue growth of 48% is strong, but the 4% ROE suggests capital efficiency is low. For a company this size, even a ₹30-40 crore issue could meaningfully dilute existing holders. The Board's decision on July 23 will be the first hard signal on the scale of the raise and the price at which new investors get in.
Questions answered
- Why is Shivalik Rasayan raising funds now?
- The company has not stated the reason. It recently reported a 41% drop in standalone net profit for FY26, which may have prompted a need for capital amid weak profitability.
- What methods of fundraising are being considered?
- The board will evaluate a preferential issue, rights issue, qualified institutions placement (QIP), or other modes. The final method will be decided on July 23.
- How dilutive could this be for existing shareholders?
- With a market cap of ₹339 crore, any issue size above ₹30-40 crore could significantly dilute earnings per share. Without specifics, the extent is unknown.
- What is the company's current financial health?
- For the March 2026 quarter, Shivalik reported sales of ₹103 crore and net profit of ₹7 crore. Trailing ROE is only 4.0%, and debt/equity is low at 0.25.
- When will investors get more details?
- The board meets on July 23, 2026. If approved, the company will likely disclose the issue size, pricing, and purpose in a subsequent filing.
- Is this a positive or negative signal?
- It is neutral to negative until details emerge. Raising equity suggests a need for cash, which could be for growth or to shore up the balance sheet, but dilution is a near-term risk.
Shivalik Rasayan Ltd.
Latest quarter · Mar 2026
Strength & growth
Story so far
All notes on SHIVALIK →- 20 Jul 2026 · 4:59 PM IST Shivalik Rasayan plans equity raise; no size or price yet
- 62d ago Shivalik Rasayan profit drops 41% as board confirms dividend
- 62d ago Shivalik Rasayan reports FY26 results and declares 10% dividend